Thomson Reuters Corp is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts, such as the company's integration of AI tools and a recent upgrade by RBC Capital, the stock is currently overbought based on RSI, and its financial performance shows declining net income and EPS. Additionally, hedge funds are selling, and the options data suggests a bearish sentiment. A hold strategy is recommended until a more favorable entry point arises.
The stock's MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 80.579, signaling the stock is overbought. The current price is $111.48, above the pivot level of $97.067, with resistance levels at $109.302 and $116.861. Moving averages are converging, suggesting indecision in the trend.

Integration of AI tools, as highlighted during Anthropic's event, which could enhance productivity and customer experience.
RBC Capital's upgrade to Outperform, citing a higher growth ceiling and potential for organic growth reacceleration.
Canaccord's buy rating and belief in the company's strong market position and shareholder returns.
Declining net income (-43.52%) and EPS (-43.08%) in Q4
Hedge funds are selling, with a 164.85% increase in selling activity over the last quarter.
CFO transition announced, which may lead to short-term uncertainty.
Quant ratings label the stock as a strong sell.
In Q4 2025, revenue increased by 5.24% YoY to $2.009 billion, but net income dropped significantly by 43.52% YoY to $331 million. EPS also declined by 43.08% YoY to $0.74. Gross margin improved by 18.27% YoY to 100%. While revenue growth is positive, the sharp decline in profitability metrics is concerning.
Analyst ratings are mixed. RBC Capital upgraded the stock to Outperform with a $126 price target, citing growth potential. However, BofA, JPMorgan, and Morgan Stanley maintain Neutral or Equal Weight ratings with price targets around $100-$116, reflecting concerns about AI disruption and growth sustainability. Canaccord and BMO Capital remain bullish with higher price targets, emphasizing the company's market position and shareholder returns.